TY - JOUR AU - Emberton, M. AU - Fitzpatrick, J. M. AU - Garcia-Losa, M. PY - 2008 DA - 2008// TI - Progression of benign prostatic hyperplasia: systematic review of the placebo arms of clinical trials JO - BJU Int VL - 102 UR - https://doi.org/10.1111/j.1464-410X.2008.07717.x DO - 10.1111/j.1464-410X.2008.07717.x ID - Emberton2008 ER - TY - JOUR AU - Briganti, A. AU - Capitanio, U. AU - Suardi, N. PY - 2009 DA - 2009// TI - Benign prostatic hyperplasia and its aetiologies JO - J Eur Urol Suppl VL - 8 UR - https://doi.org/10.1016/j.eursup.2009.11.002 DO - 10.1016/j.eursup.2009.11.002 ID - Briganti2009 ER - TY - JOUR AU - Rhodes, T. AU - Girman, C. J. AU - Jacobsen, S. J. PY - 1999 DA - 1999// TI - Longitudinal prostate growth rates during 5 years in randomly selected community men 40 to 79 years old JO - J Urol VL - 161 UR - https://doi.org/10.1016/S0022-5347(01)61621-5 DO - 10.1016/S0022-5347(01)61621-5 ID - Rhodes1999 ER - TY - JOUR AU - Roehrborn, C. G. AU - Barkin, J. AU - Siami, P. PY - 2011 DA - 2011// TI - Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial JO - BJU Int VL - 107 UR - https://doi.org/10.1111/j.1464-410X.2011.10124.x DO - 10.1111/j.1464-410X.2011.10124.x ID - Roehrborn2011 ER - TY - JOUR AU - McConnell, J. D. AU - Roehrborn, C. G. AU - Bautista, O. M. PY - 2003 DA - 2003// TI - The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia JO - N Engl J Med VL - 349 UR - https://doi.org/10.1056/NEJMoa030656 DO - 10.1056/NEJMoa030656 ID - McConnell2003 ER - TY - JOUR AU - Roehrborn, C. G. AU - McConnell, J. AU - Bonilla, J. PY - 2000 DA - 2000// TI - Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study JO - J Urol VL - 163 UR - https://doi.org/10.1016/S0022-5347(05)67962-1 DO - 10.1016/S0022-5347(05)67962-1 ID - Roehrborn2000 ER - TY - JOUR AU - Roehrborn, C. G. AU - Malice, M. AU - Cook, T. J. PY - 2001 DA - 2001// TI - Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPH: a comprehensive analysis of the pooled placebo groups of several large clinical trials JO - Urology VL - 58 UR - https://doi.org/10.1016/S0090-4295(01)01155-4 DO - 10.1016/S0090-4295(01)01155-4 ID - Roehrborn2001 ER - TY - JOUR AU - Roehrborn, C. G. AU - McConnell, J. D. AU - Lieber, M. PY - 1999 DA - 1999// TI - Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group JO - Urology VL - 53 UR - https://doi.org/10.1016/S0090-4295(98)00654-2 DO - 10.1016/S0090-4295(98)00654-2 ID - Roehrborn1999 ER - TY - JOUR AU - Park, D. S. AU - Hong, J. Y. AU - Hong, Y. K. PY - 2013 DA - 2013// TI - Correlation between serum prostate specific antigen level and prostate volume in a community-based cohort: large-scale screening of 35,223 Korean men JO - Urology VL - 82 UR - https://doi.org/10.1016/j.urology.2013.07.071 DO - 10.1016/j.urology.2013.07.071 ID - Park2013 ER - TY - JOUR AU - Roehrborn, C. G. AU - Siami, P. AU - Barkin, J. PY - 2009 DA - 2009// TI - The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study JO - Eur Urol VL - 55 UR - https://doi.org/10.1016/j.eururo.2008.10.037 DO - 10.1016/j.eururo.2008.10.037 ID - Roehrborn2009 ER - TY - JOUR AU - Chan, Y. H. PY - 2003 DA - 2003// TI - Biostatistics 102: quantitative data-parametric and non-parametric tests JO - Singap Med J VL - 44 ID - Chan2003 ER - TY - JOUR AU - Chan, Y. H. PY - 2003 DA - 2003// TI - Biostatistics 104: correlational analysis JO - Singap Med J VL - 44 ID - Chan2003 ER - TY - JOUR AU - Lepor, H. PY - 1998 DA - 1998// TI - Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Tamsulosin Investigator Group JO - Urology VL - 51 UR - https://doi.org/10.1016/S0090-4295(98)00126-5 DO - 10.1016/S0090-4295(98)00126-5 ID - Lepor1998 ER - TY - JOUR AU - Narayan, P. AU - Evans, C. P. AU - Moon, T. PY - 2003 DA - 2003// TI - Long-term safety and efficacy of tamsulosin for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia JO - J Urol VL - 170 UR - https://doi.org/10.1097/01.ju.0000076140.68657.fd DO - 10.1097/01.ju.0000076140.68657.fd ID - Narayan2003 ER - TY - JOUR AU - Burroughs, V. J. AU - Maxey, R. W. AU - Levy, R. A. PY - 2002 DA - 2002// TI - Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment JO - J Natl Med Assoc VL - 94 ID - Burroughs2002 ER - TY - JOUR AU - Chapple, C. R. AU - Montorsi, F. AU - Tammela, T. L. PY - 2011 DA - 2011// TI - Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe JO - Eur Urol VL - 59 UR - https://doi.org/10.1016/j.eururo.2010.10.046 DO - 10.1016/j.eururo.2010.10.046 ID - Chapple2011 ER - TY - JOUR AU - Schulman, C. C. AU - Lock, T. M. AU - Buzelin, J. M. PY - 2001 DA - 2001// TI - Long-term use of tamsulosin to treat lower urinary tract symptoms/benign prostatic hyperplasia JO - J Urol VL - 166 UR - https://doi.org/10.1016/S0022-5347(05)65769-2 DO - 10.1016/S0022-5347(05)65769-2 ID - Schulman2001 ER - TY - JOUR AU - Gratzke, C. AU - Bachmann, A. AU - Descazeaud, A. PY - 2015 DA - 2015// TI - EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction JO - Eur Urol VL - 67 UR - https://doi.org/10.1016/j.eururo.2014.12.038 DO - 10.1016/j.eururo.2014.12.038 ID - Gratzke2015 ER -